Congenital heart disease and cardiac procedural outcomes in patients with trisomy 21 and Turner syndrome

2017 ◽  
Vol 12 (6) ◽  
pp. 820-827 ◽  
Author(s):  
Raysa Morales-Demori
Keyword(s):  
Congenital Heart Disease ◽  
Heart Disease ◽  
Turner Syndrome ◽  
Trisomy 21 ◽  
Congenital Heart ◽  
Procedural Outcomes

Monitoring of congenital heart disease (CHD) and aortic dilatation in Turner syndrome: Italian experience

2006 ◽  
Vol 1298 ◽  
pp. 123-130 ◽  
Author(s):  
L. Mazzanti ◽  
D. Prandstraller ◽  
R. Fattori ◽  
L. Lovato ◽  
A. Cicognani
Keyword(s):  
Congenital Heart Disease ◽  
Heart Disease ◽  
Turner Syndrome ◽  
Congenital Heart ◽  
Aortic Dilatation ◽  
Italian Experience

Congenital heart disease in trisomy 21 mosaicism

1993 ◽  
Vol 122 (3) ◽  
pp. 500-501 ◽  
Author(s):  
Bruno Marino ◽  
Andrea de Zorzi
Keyword(s):  
Congenital Heart Disease ◽  
Heart Disease ◽  
Trisomy 21 ◽  
Congenital Heart

Tissue-specific mosaicism for trisomy 21 and congenital heart disease

1992 ◽  
Vol 121 (1) ◽  
pp. 80-82 ◽  
Author(s):  
Yuji Yokoyama ◽  
Kouji Narahara ◽  
Masahiro Kamada ◽  
Kazushiro Tsuji ◽  
Yoshiki Seino
Keyword(s):  
Congenital Heart Disease ◽  
Heart Disease ◽  
Trisomy 21 ◽  
Congenital Heart ◽  
Tissue Specific

Emerging 3D technologies and applications within congenital heart disease: teach, predict, plan and guide

2020 ◽  
Author(s):  
Arash Salavitabar ◽  
C Alberto Figueroa ◽  
Jimmy C Lu ◽  
Sonal T Owens ◽  
David M Axelrod ◽  
...  
Keyword(s):  
Congenital Heart Disease ◽  
Heart Disease ◽  
Congenital Heart ◽  
3D Visualization ◽  
3D Models ◽  
Team Members ◽  
Procedural Guidance ◽  
Procedural Success ◽  
Procedural Planning ◽  
Procedural Outcomes

3D visualization technologies have evolved to become a mainstay in the management of congenital heart disease (CHD) with a growing presence within multiple facets. Printed and virtual 3D models allow for a more comprehensive approach to educating trainees and care team members. Computational fluid dynamics can take 3D modeling to the next level, by predicting post-procedural outcomes and helping to determine surgical approach. 3D printing and extended reality are developing resources for pre-procedural planning and intra-procedural guidance with the potential to revolutionize decision-making and procedural success. Challenges still remain within existing technologies and their applications to the CHD field. Addressing these gaps, both by those within and outside of CHD, will transform education and patient care within our field.

scholarly journals Comorbidities in children with Down syndrome: experience in a tertiary care hospital of Bangladesh

2021 ◽  
Vol 11 (3) ◽  
pp. 191-196
Author(s):  
Fahmida Zabeen ◽  
Fauzia Mohsin ◽  
Eva Jesmin ◽  
Sharmin Mahbuba ◽  
M Quamrul Hassan
Keyword(s):  
Congenital Heart Disease ◽  
Down Syndrome ◽  
Heart Disease ◽  
Trisomy 21 ◽  
Congenital Heart ◽  
Thyroid Dysfunction ◽  
Septal Defect ◽  
Tertiary Care ◽  
Care Hospital ◽  
Children With Down Syndrome

Background: Down syndrome or trisomy 21 is one of the most common chromosomal disorders with moderate intellectual disability. In addition to mental retardation, this syndrome is associated with different congenital anomalies and characteristic dysmorphic features. Affected individuals are more susceptible to congenital heart disease and digestive anomalies, pulmonary complications, immune and endocrine system disorders. While several international studies have shown association of co-morbidities with trisomy 21, there is insufficient data available in Bangladesh.The present study aimed to evaluate the associated co-morbidities in children with Down syndrome. Methods: A cross-sectional study was conducted among pediatric cases with Down syndrome who attended the endocrine outpatient department (OPD) of BIRDEM General Hospital from June 2006 to December 2016. The cases were diagnosed either by Karyotyping or by characteristic phenotypes.The clinical and laboratory data of the patients were collected from outpatient history records for analysis. Results: There were total 42 children with Down syndrome, with mean age 4.2 years at assessment and female predominance (1.47:1). Thyroid dysfunction was the most common (69%) followed by congenital heart disease (57%). Among the thyroid disorders, acquired hypothyroidism was found in 55% cases, congenital hypothyroidism in 41% cases and only one had hyperthyroidism. Isolated patent ductus arteriosus (PDA) and atrial septal defect (ASD) comprised the commonest single congenital heart disease found in 53% and combined atrioventricular septal defect was the commonest among complex congenital cardiac defect observed in our study. Both thyroid dysfunction and congenital heart disease were found more in female children with Down syndrome than their male counterpart and it was found statistically significant. Fifty percent of our Down syndrome cases were referred from other healthcare centers to address developmental delay. Conclusion: Hypothyroidism and congenital heart disease are frequently associated in Down syndrome children in Bangladesh. This calls for developing awareness among health professionals to diagnose comorbidities at an early stage and to form recommendations for long term follow up. BIRDEM Med J 2021; 11(3): 191-196

scholarly journals 749: A RARE CASE OF BOTULISM WITH ENCEPHALOPATHY IN A BABY WITH TRISOMY 21 AND CONGENITAL HEART DISEASE

2021 ◽  
Vol 50 (1) ◽  
pp. 368-368
Author(s):  
Jeremy Sites ◽  
Laura Rachal ◽  
Nathaniel Wooten ◽  
Diana Cejas ◽  
Zachary Willis ◽  
...  
Keyword(s):  
Congenital Heart Disease ◽  
Heart Disease ◽  
Trisomy 21 ◽  
Rare Case ◽  
Congenital Heart

Pulmonary hypertension associated with congenital heart disease

2020 ◽  
pp. 313-332
Author(s):  
Ryan Coleman ◽  
Corey Chartan ◽  
Nidhy Varghese
Keyword(s):  
Congenital Heart Disease ◽  
Pulmonary Hypertension ◽  
Heart Disease ◽  
Trisomy 21 ◽  
Congenital Heart ◽  
Pulmonary Arteries ◽  
Pulmonary Vascular Disease ◽  
Single Ventricle Physiology ◽  
Vascular Bed ◽  
Therapeutic Considerations

The spectrum of pulmonary hypertension associated with congenital heart disease (PH-CHD) is broad and complex. The most common aetiologies are related to left-to-right shunts, resulting in volume loading of the pulmonary circulation (precapillary pulmonary hypertension) and left-sided obstructive disease (post-capillary pulmonary hypertension). However, in addition to these basic classifications are patients with absent pulmonary arteries, large septal defects, duct-dependent lesions, cardiomyopathies, and, perhaps the most challenging, patients with single ventricle physiology lacking a subpulmonic ventricle. It is therefore imperative that physicians taking care of children with PH-CHD are well versed not only in the different physiologies present in these children, but also in those that result from their respective surgical palliations as well and how these flows and pressures relate to their pulmonary vascular disease burden. This chapter presents the case of a child with trisomy 21 and congenital heart disease who presented late to medical care and required significant modulation of her pulmonary vascular bed to successfully undergo surgical correction. The child’s clinical course, an overview of PH-CHD and its diagnosis and management, and important therapeutic considerations are presented.

Sign in / Sign up

Export Citation Format

Share Document